Company: AZN
Filing Date: 2025-12-19
Form Type: 6-K
Source: 0001654954-25-014136
Chunk: 1

Company: ASTRAZENECA PLC
Filing Date: 2025-12-19
Form: 6-K
Chunk 1
---
, 
                     auction platform, auctioneer or auction monitor |                                                    |           |
| a) |                                                                Name | AstraZeneca                                        
 PLC                                                |           |
| b) |                                                                 LEI | PY6ZZQWO2IZFZC3IOL08                               |           |
| 4  |  Details of the transaction(s): section to be repeated for (i) each 
 type of instrument; (ii) each type of transaction; (iii) each date; 
                    and (iv) each place where transactions have been 
                                                           conducted |                                                    |           |
| a) |                    Description of the financial instrument, type of 
                                                          instrument 
                                                      Identification 
                                                                code | Ordinary Shares of US$0.25 each in AstraZeneca PLC 
 GB0009895292                                       |           |
| b) |                                           Nature of the transaction | Receipt                                            
 of gift of shares for nil consideration            |           |
| c) |                                              Price(s) and volume(s) | Price(s)                                           | Volume(s) |
| 0  |                                                               5,735 |                                                    |           |
| d) |                                              Aggregated information 
                                                 - Aggregated volume 
                                                             - Price | Not applicable - single transaction                |           |
| e) |                                             Date of the transaction | 17                                                 
 December 2025                                      |           |
| f) |                                            Place of the transaction | Outside                                            
 a trading venue                                    |           |

#### AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit www.astrazeneca.com and follow the Company on social media @AstraZeneca .

#### Contacts
For details on how to contact the Investor Relations Team, please click here . For Media contacts, click here .

#### Matthew Bowden

#### Company Secretary

#### AstraZeneca PLC
<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned